Neurology Devices are specialized surgical devices used for the treatment of disease or conditions of the Central Nervous System (CNS) and spine. Neuromodulation devices are implantable electrical devices that are used to typically treat chronic pain, by modulating pathways in the spinal cord leading to blocking transmission of pain signals to the brain. GlobalData uses proprietary data and analytics to provide a comprehensive report on the neuromodulation devices market in Poland. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the neuromodulation devices market in Poland was Medtronic followed by LivaNova, Boston Scientific, Abbott Laboratories, B. Braun Melsungen, IntraPace, Nevro, Xavant Technology, Bioness and ReShape Lifesciences.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Neuromodulation devices include Deep Brain Stimulators (DBS), Gastric Electric Stimulators (GES), Leads, Sacral Nerve Stimulators (SNS), Spinal Cord Stimulators (SCS), Peripheral Nerve Stimulators (PNS) and Vagus Nerve Stimulators (VNS). A DBS is a device that is comprised of a brain-oriented pacemaker (an implantable pulse generator) that sends electrical stimulation through surgically implanted electrodes to specific targets in the brain. GES are utilized to treat gastroparesis, a medical condition where weak muscular contractions (peristalsis) of the stomach results in food and liquid remaining in the stomach for an extended period, leading to irregular absorption of nutrients, inadequate nutrition, and poor glycemic control. An SNS is a device comprised of a subcutaneously implanted electrical pacemaker that sends low electrical stimulation through surgically implanted electrodes to target the sacral nerve. An SCS is a device that comprises a surgically implanted electrical pacemaker and electrodes that connect to the spinal cord to treat chronic pain disorders. A PNS is a device, similar to the SCS that is used to treat chronic pain disorders. A VNS is a device comprised of an electrical pacemaker that sends electrical stimulation through surgically implanted electrodes to target the vagus nerve. Lead is a set of thin wires covered with a protective coating. It carries the therapy signal to the electrodes that deliver stimulation to the target of interest.
The neuromodulation devices market in Poland can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size neuromodulation devices in Poland, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
